1. Home
  2. PPSI vs VERU Comparison

PPSI vs VERU Comparison

Compare PPSI & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$3.99

Market Cap

46.2M

Sector

Industrials

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.12

Market Cap

40.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
VERU
Founded
2008
1971
Country
United States
United States
Employees
58
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.2M
40.9M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
PPSI
VERU
Price
$3.99
$2.12
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.50
AVG Volume (30 Days)
275.4K
56.4K
Earning Date
04-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,627,000.00
$16,296,958.00
Revenue This Year
$2.71
N/A
Revenue Next Year
$22.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.75
N/A
52 Week Low
$2.35
$0.36
52 Week High
$5.70
$4.59

Technical Indicators

Market Signals
Indicator
PPSI
VERU
Relative Strength Index (RSI) 55.79 36.49
Support Level $3.94 $0.36
Resistance Level $4.49 $2.67
Average True Range (ATR) 0.41 0.10
MACD 0.03 -0.01
Stochastic Oscillator 48.18 18.18

Price Performance

Historical Comparison
PPSI
VERU

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets. The Company launched two new product platforms namely, PRYMUS, a new, mobile on-site power system concentrating on customers with requirements of 1-10 megawatts of mobile power and PowerCore, a residential and small commercial based primary generator system integrating a DC fast charger into one solution.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: